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This is an open access artiIntroductionThe family Flavobacteriaceae, which formerly belonged to the
Cytophaga–Flexibacter–Bacteroides group, represents the most
important bacterial lineage in the phylum Bacteroidetes [1].
Likewise, Chryseobacterium, Bergeyella, Ornithobacterium, Empe-
dobacter, Weeksella, Wautersiella, Elizabethkingia, Sejongia and
Kaistella are the genera currently included in this family [1–3].
However, Kaistella ﬂava and Kaistella korensis are reclassiﬁed in
the genus Chryseobacterium [4,5]. The genus Chryseobacterium
was proposed for the ﬁrst time in 1994 [2]. Currently 90
species with validly published names are included in this genus
[6]. Members of this genus have been isolated from a variety of
environments, including soil [7,8], plant rhizosphere [9],
wastewater [10], freshwater [11], compost [12], diseased ﬁsh
[13] and clinical samples [14,15]. Chryseobacterium FF12T strain
(CSUR = P1490, DSM 100279) is the type strain of Chrys-
eobacterium senegalense sp. nov. It was isolated from the mouth
of a West African lungﬁsh (Protopterus annectens). Cells are
Gram negative, aeroanaerobic, nonmotile, non–spore forming
and rods. The availability of genomic data for many bacterial
species [16] inspired us to propose a new concept for the
description of new bacterial species, integrating proteomic in-
formation obtained by matrix-assisted laser desorption/ioniza-
tion time-of-ﬂight mass spectrometry (MALDI-TOF) [17] and
genomic sequencing [18]. This concept changes the current
methods of deﬁning a new bacterial species, which are based on
genetic, phenotypic and chemotaxonomic criteria that are
poorly reproducible and cannot be applied to the entire bac-
terial genus [19–21].
Here we present a summary classiﬁcation and a set of fea-
tures for the type strain Chryseobacterium senegalense sp. nov.,
strain FF12T (CSUR = P1490, DSM 100279), together with the
description of the complete genomic sequence and its anno-
tation. These characteristics support the circumscription of the
species Chryseobacterium senegalense.
Organism InformationClassiﬁcation and features
The strain FF12T was isolated from the mouth of a West
African lungﬁsh (Protopterus annectens) in Senegal in June 2014
(Table 1). A sterile swab was introduced in the mouth of this
ﬁsh. The sample was inoculated on a 5% sheep’s blood–
enriched Columbia agar (bioMérieux, Marcy L’Etoile, France)
and incubated at 37°C during 48 hours. First identiﬁcation of
this strain by MALDI-TOF in Dakar was attempted [30]. Then
in Marseille MALDI-TOF protein analysis was performed usingNew Microbe and New Infect 2016; 10: 93–100
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TABLE 1. Classiﬁcation and general features of
Chryseobacterium senegalense strain FF12T [22]
MIGS ID Property Term
Evidence
codea
Classiﬁcation Domain: Bacteria TAS [23]
Phylum: Bacteroidetes TAS [24,25]
Class: Flavobacteriia TAS [25,26]
Order: Flavobacteriales TAS [27,28]
Family: Flavobacteriaceae TAS [1]
Genus: Chryseobacterieum TAS [2]
Species: Chryseobacterieum
senegalense
IDA
(Type) strain: FF12T IDA
Gram stain Negative IDA
Cell shape Rod IDA
Motility Nonmotile IDA
Sporulation Non–spore forming NAS
Temperature range Mesophile IDA
Optimum temperature 37°C IDA
pH range; optimum 6.0–6.4; 6.2
Carbon source Unknown
MIGS-6 Habitat Fish IDA
MIGS-6.3 Salinity Unknown
MIGS-22 Oxygen requirement Aeroanaerobic TAS
MIGS-15 Biotic relationship Free-living TAS
MIGS-14 Pathogenicity Unknown
MIGS-4 Geographic location Senegal TAS
MIGS-5 Sample collection 5 June 2014 TAS
MIGS-4.1 Latitude 14.6937000 TAS
MIGS-4.1 Longitude −17.4440600 TAS
MIGS-4.4 Altitude 12 m above sea level TAS
MIGS, minimum information about a genome sequence.
aEvidence codes are as follows: IDA, inferred from direct assay; TAS, traceable
author statement (i.e. a direct report exists in the literature); NAS, nontraceable
author statement (i.e. not directly observed for the living, isolated sample, but based
on a generally accepted property for the species or anecdotal evidence). These
evidence codes are from the Gene Ontology project (http://www.geneontology.
org/GO.evidence.shtml) [29]. If the evidence code is IDA, then the property should
have been directly observed, for the purpose of this speciﬁc publication, for a live
isolate by one of the authors, or by an expert or reputable institution mentioned in
the acknowledgements.
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viously reported [31]. An isolated colony was deposited in
duplicate on a MALDI-TOF target for analysis. Scores ranging
from 1.23 to 1.47 were obtained for FF12T, suggesting that
this strain was not a member of any known species in the
MALDI-TOF database. The reference mass spectrum from
strain FF12T was incremented in our database (Fig. 1). Col-
onies that remained unidentiﬁed with MALDI-TOF after three
tests are used for amplifying and sequencing the 16S rRNA
sequence, as previously described elsewhere [32,33]. Chrys-
eobacterium senegalense sp. nov. exhibited a 97.97% 16S rRNA
sequence similarity with Kaistella ﬂava [34], the phylogeneti-
cally closest bacterial species with standing in the nomencla-
ture (Fig. 2). These values were lower than the 98.7% 16S
rRNA gene sequence threshold recommended by Meier-
Kolthoff et al. [37] in 2013 to delineate a new species within
the phylum Bacteroidetes without carrying out DNA-DNA
hybridization.
Different growth temperatures (25, 28, 37, 45 and 56°C)
were tested. Growth was obtained between 25 and 37°C, with
optimal growth at 28 and 37°C. Growth of the strain was also
tested under anaerobic and microaerophilic conditions using
GENbag anaer and GENbag microaer systems respectivelyNew Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf of
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CO2. Optimal growth was observed under aerobic and micro-
aerophilic conditions. Weak growth was observed under
anaerobic conditions at 25°C only. The colonies were opaque
and light yellow in color, with a smooth surface on 5% sheep’s
blood–enriched Columbia agar and approximately 1 mm in
diameter. A motility test was negative. Cells were Gram-
negative, non-spore-forming rods (Fig. 3) with a mean diameter
of 0.75 μm (range 0.5–1 μm) and a mean length of 2.25 μm
(range 1.5–3 μm) (Fig. 4). Strain FF12T was oxidase and catalase
positive. Using an API ZYM strip (bioMérieux), positive reactions
were observed for alkaline phosphatase, phosphatase acid,
esterase, lipase, leucine arylamidase, α-glucosidase, β-glucosidase,
naphthol-AS-BI-phosphohydrolase, α-fucosidase, β-galactosidase
and α-galactosidase. Negative reactions were noted for
β-glucuronidase, α-mannosidase, N-acetyl-β-glucosaminidase,
α-chymotrypsin and cystine arylamidase. Using an API 50CH
strip (bioMérieux), positive reactions were observed for D-
glucose, D-maltose and starch. Negative reactions were observed
for D-melibiose, D-trehalose, D-saccharose, D-rafﬁnose, inositol,
D-fructose, potassium 5-ketogluconate, D-mannitol, D-sorbitol, L-
xylose, D-adonitol, methyl β-D-xylopyranoside, glycerol, ribose,
D-xylose, D-mannose, D-melezitose and inulin. Four species with
validly published names in the Flavobacteriaceae family were
selected to make a phenotypic comparison with C. senegalense
(Table 2). By comparison with other closer related Chrys-
eobacterium species, C. senegalense differed in β-galactosidase
production and 5-keto-gluconate utilization. The strain FF12T is
susceptible to amoxicillin, amoxicillin/clavulanic acid, ceftriaxone,
trimethoprim/sulfamethoxazole, erythromycin, ciproﬂoxacin,
nitrofurantoin, doxycycline, rifampicin and imipenem but resis-
tant to gentamicin and metronidazole.Genome Sequencing InformationGenome sequencing and assembly
Genomic DNA (gDNA) of Chryseobacterium senegalense was
sequenced on the MiSeq Technology (Illumina, San Diego, CA,
USA) with the mate pair strategy. The gDNA was barcoded in
order to be mixed with 11 other projects with the Nextera
mate pair sample prep kit (Illumina). The biomass of one petri
dish was scraped and resuspended in 500 μL phosphate-
buffered saline. A total of 100 μL of this bacterial suspension
was spun, and the pellet was resuspended in 160 μL of G2
buffer from the EZ1 DNA Tissue kit (Qiagen, Venlo,
Netherlands). A ﬁrst mechanical lysis was performed by glass
powder on the FastPrep-24 device (MP Biomedicals, Santa Ana,
CA, USA) during 2 × 20 seconds. DNA was then incubated
with 40 μL of lysozyme at 40 mg/mL for 30 minutes at 37°C andEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 10, 93–100
nses/by-nc-nd/4.0/)
FIG. 1. Reference mass spectrum from Chryseobacterium senegalense strain FF12T spectra.
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an elution volume of 50 μL.
DNA was quantiﬁed by a Qubit assay with the high sensi-
tivity kit (Life Technologies, Carlsbad, CA, USA) to 28.5 ng/μL.
The mate pair library was prepared with 1 μg of genomic DNA
using the Nextera mate pair Illumina guide. The genomic DNA
sample was simultaneously fragmented and tagged with a mate
pair junction adapter. The pattern of the fragmentation was
validated on an Agilent 2100 Bioanalyzer (Agilent Technologies,
Santa Clara, CA, USA) with a DNA 7500 LabChip. The DNA
fragments ranged in size from 1 to 10 kb, with an optimal size at
3.5 kb. No size selection was performed, and only 479 ng of
tagmented fragments were circularized. The circularized DNA
was mechanically sheared to small fragments with 641 bp on a
Covaris S2 device in microtubes (Covaris, Woburn, MA, USA).
The library proﬁle was visualized on a High Sensitivity Bio-
analyzer LabChip (Agilent), and the ﬁnal concentration library
was measured at 57.9 nmol/L.
The libraries were normalized at 2 nM and pooled. After a
denaturation step and dilution at 15 pM, the pool of libraries
was loaded onto the reagent cartridge and then onto the in-
strument along with the ﬂow cell. Automated cluster genera-
tion and sequencing runs were performed in a single 27-hourNew Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf
This is an open access artirun at 2 × 251 bp. A total of 8.6 Gb of information was ob-
tained from a 950K/mm2 cluster density, with a cluster passing
quality control ﬁlters of 93.2% (18 182 000 clusters). Within
this run, the index representation for Chryseobacterium sene-
galense was determined to be 8.35%. The 1 414 815 paired
reads were ﬁltered according to the read qualities. These reads
were trimmed and then assembled using the CLC genomics
WB4 software.
Genome annotation and comparison
Open reading frames (ORFs) were predicted using Prodigal
[42] with default parameters, but the predicted ORFs were
excluded if they spanned a sequencing gap region. The pre-
dicted bacterial protein sequences were searched against the
GenBank database [43] and the Clusters of Orthologous
Groups (COGs) databases using BLASTP. The tRNAscan-SE
tool [44] was used to ﬁnd tRNA genes, whereas ribosomal
RNAs were found using RNAmmer [45] and BLASTn against
the GenBank database. Lipoprotein signal peptides and the
number of transmembrane helices were predicted using SignalP
[46] and TMHMM [47] respectively. ORFans were identiﬁed if
their BLASTP E value was lower than 1e-03 for an alignment
length greater than 80 amino acids. If the alignment lengthsof European Society of Clinical Microbiology and Infectious Diseases, NMNI, 10, 93–100
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
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FIG. 2. Phylogenetic tree highlighting position of Chryseobacterium
senegalense strain FF12T (LN810503) relative to other type strains
within Flavobacteriaceae family. GenBank accession numbers are indi-
cated in parentheses. Sequences were aligned using MUSCLE [35], and
phylogenetic tree was inferred by Maximum Likelihood method with
Kimura two-parameter model from MEGA6 software [36]. Numbers at
nodes are percentages of bootstrap values obtained by repeating anal-
ysis 1000 times to generate majority consensus tree. Riemerella colum-
bina was used as outgroup. Scale bar = 0.1% nucleotide sequence
divergence.
FIG. 4. Transmission electron microscopy of Chryseobacterium sene-
galense strain FF12T. Cells are observed on Tecnai G2 transmission
electron microscope operated at 200 keV. Scale bar = 500 nm.
96 New Microbes and New Infections, Volume 10 Number C, March 2016 NMNIwere smaller than 80 amino acids, we used an E value of 1e-05.
Such parameter thresholds have already been used in previous
works to deﬁne ORFans. Artemis [48] was used for data
management and DNA Plotter [49] to visualize genomic fea-
tures. The Mauve alignment tool (version 2.3.1) was used for
multiple genomic sequence alignment [50]. To estimate the
mean level of nucleotide sequence similarity at the genomeFIG. 3. Gram staining of Chryseobacterium senegalense strain FF12T.
New Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf of
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average genomic identity of gene sequences (AGIOS) among
compared genomes [18]. Brieﬂy, this software combines the
Proteinortho software [51] for detecting orthologous proteins
in pairwise genomic comparisons, then retrieves the corre-
sponding genes and determines the mean percentage of
nucleotide sequence identity among orthologous ORFs using
the Needleman-Wunsch global alignment algorithm. Genomes
from the genus Chryseobacterium and closely related genera
were used to calculate AGIOS values.
The genome of Chryseobacterium senegalense strain
FF12T (GenBank accession no. CYUH01000001–CYUH0100
0015CYUH01000001CYUH01000002CYUH01000003-
CYUH01000004CYUH01000005CYUH01000006CYUH010
00007CYUH01000008CYUH01000009CYUH01000010CYUH
01000011CYUH01000012CYUH01000013CYUH01000014-
CYUH01000015) was compared to Chryseobacterium haifense
strain DSM 19056T (GenBank accession no. JASZ00000000),
Chryseobacterium indologenes strain NBRC 14944T (GenBank
accession no. BAVL01000000), Chryseobacterium formosense
strain LMG 24722 (GenBank accession no. JPRP00000000) and
Elizabethkingia miricola strain ATCC 33958 (GenBank accession
no. JRFN00000000).
Genome properties
The GenBank BioProject number is PRJEB10923. The draft
genome of C. senegalense FF12T consists of 68 contigs and
generated a 4 397 629 bp long genome with a 35.1% G+C
content (Fig. 5). Of the 4056 predicted genes, 4001 were
protein-coding genes, three were RNAs (one 5S rRNA gene,European Society of Clinical Microbiology and Infectious Diseases, NMNI, 10, 93–100
nses/by-nc-nd/4.0/)
TABLE 2. Differential characteristics of Chryseobacterium senegalense strain FF12T (data from this study), Chryseobacterium haifense
[38], Chryseobacterium hispalense [39], Chryseobacterium formosense [40] and Elizabethkingia meningoseptica [41]
Character C. senegalense C. haifense C. hispalense C. formosense E. meningoseptica
Cell diameter (μm) 0.5–1 0.6–0.9 0.2–0.6 0.5–1 0.5–1.0
Oxygen requirement Aeroanaerobic Aerobic Aerobic Aerobic Aerobic
Gram stain − − − − −
Motility − − − − −
Endospore forming − − − − −
Catalase + + + NA +
Oxidase + + + + +
Alkaline phosphatase + + + + +
Nitrate reductase − − + − −
Acid production from:
Trehalose + NA − + +
D-Glucose + + + + +
Mannose + + + + NA
Rhamnose + NA + + NA
Mannitol − − − + +
Naphthol-AS-BI-phosphohydrolase + NA + + +
β-Galactosidase + NA − − +
N-acetyl-β-glucosaminidase − NA − − NA
Utilization of:
5-keto-gluconate − NA + + NA
D-Xylose − − NA + +
D-Fructose + + + − +
L-Fucose − NA + − NA
D-Arabitol − NA NA + NA
Habitat Fish Raw milk Clinical samples Rhizosphere Human
NA, not available.
FIG. 5. Graphical circular map of genome. From outside to center, contigs (red/grey), COGs category of genes on forward S strand (three circles),
genes on forward strand (blue circle), genes on reverse strand (red circle), COGs category on reverse strand (three circles), GC content.
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TABLE 3. Nucleotide content and gene count levels of
genome
Attribute Value % of totala
Size (bp) 4 397 629 bp 100
G+C content (bp) 1 543 567 bp 35.1
Coding region (bp) 3 945 189 bp 89.71
Total genes 4056 100
RNA genes 55 1.35
Protein-coding genes 4001 98.64
Genes with function prediction 2385 58.80
Genes assigned to COGs 2118 52.21
Genes with peptide signals 478 11.78
Genes with transmembrane helices 819 20.19
COGs, Clusters of Orthologous Groups database.
aTotal is based on either size of genome (bp) or total number of protein-coding
genes in annotated genome.
TABLE 4. Number of genes associated with 25 general COGs
functional categoriesa
Code Value % value Description
J 142 3.54 Translation
A 0 0 RNA processing and modiﬁcation
K 147 3.67 Transcription
L 133 3.32 Replication, recombination and repair
B 0 0 Chromatin structure and dynamics
D 23 0.57 Cell cycle control, mitosis and meiosis
Y 0 0 Nuclear structure
V 59 1.47 Defense mechanisms
T 79 1.97 Signal transduction mechanisms
M 186 4.64 Cell wall/membrane biogenesis
N 2 0.04 Cell motility
Z 0 0 Cytoskeleton
W 0 0 Extracellular structures
U 24 0.59 Intracellular trafﬁcking and secretion
O 93 2.32 Posttranslational modiﬁcation, protein
turnover, chaperones
C 116 2.89 Energy production and conversion
G 90 2.24 Carbohydrate transport and metabolism
E 157 3.92 Amino acid transport and metabolism
F 55 1.37 Nucleotide transport and metabolism
H 91 2.27 Coenzyme transport and metabolism
I 72 1.79 Lipid transport and metabolism
P 187 4.67 Inorganic ion transport and metabolism
Q 84 2.09 Secondary metabolites biosynthesis,
transport and catabolism
R 254 6.34 General function prediction only
S 333 8.32 Function unknown
— 267 6.67 Not in COGs
COGs, Clusters of Orthologous Groups database.
aTotal is based on total number of protein-coding genes in annotated genome.
TABLE 5. Numbers of orthologous proteins shared between
genomes (upper right) and AGIOS values obtained (lower
left)a
CS CF CH CI EM
CS 4001 2259 1517 2356 1964
CF 77.41 3695 1477 2274 1881
CH 64.29 64.78 2085 1538 1381
CI 76.28 74.70 63.91 4192 1980
EM 66.59 66.41 61.15 66.95 4052
AGIOS, average genomic identity of orthologous gene sequences; CF,
Chryseobacterium formosense; CH, Chryseobacterium haifense; CI, Chryseobacterium
indologenes; CS, Chryseobacterium senegalense; EM, Elizabethkingia miricola.
aShown is average percentage similarity of nucleotides corresponding to ortholo-
gous protein shared between genomes (lower left) and numbers of proteins per
genome (bold).
TABLE 6. Pairwise comparisons of Chryseobacterium species
using GGDC, formula 2 (DDH estimates based on identities/
HSP length)a
CS CF CH CI EM
CS 100.00% 22.9% ± 2.91 21.4% ± 2.58 22.7% ± 2.83 22.0% ± 2.59
CF 100.00 19.8% ± 2.58 21.8% ± 2.73 19.7% ± 2.57
CH 100.00% 27.2% ± 2.59 24.9% ± 2.58
CI 100.00% 22.3% ± 2.60
EM 100.00%
CF, C. formosense; CH, C. haifense; CI, C. indologenes; CS, C. senegalense; DDH,
DNA-DNA hybridization; EM, Elizabethkingia miricola; GGDC, Genome-to-
Genome Distance Calculator; HSP, high-scoring segment pair.
aConﬁdence intervals indicate inherent uncertainty in estimating DDH values from
intergenomic distances based on models derived from empirical test data sets
(which are always limited in size) [52]. Formula 2 is recommended, particularly for
draft genomes [53].
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genes assigned a putative function. A total of 56 genes were
identiﬁed as ORFans (1.38%). The remaining genes were an-
notated as hypothetical proteins. The genome properties and
statistics are summarized in Table 3. The distribution of genes
into COGs functional categories is presented in Table 4.
Genome comparison
The draft genome of C. senegalense is larger than that of
C. haifense and C. formosense (4.39, 2.85 and 4.36 Mb respec-
tively) but smaller than that of C. indologenes and E. miricola
(4.75 and 4.58 Mb respectively). The G+C content of
C. senegalense is higher than that of C. formosense (35.1 andNew Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/lice34.8% respectively) but lower than that of C. haifense, C. indo-
logenes and E. miricola (36.7, 37.2, and 35.9% respectively). The
gene content of C. senegalense is higher than that of C. haifense
and C. formosense (4001, 2085 and 3695 respectively) but lower
than that of C. indologenes and E. miricola (4258 and 4159
respectively). However, the distribution of genes into COGs
categories was similar in all compared genomes. In addition,
C. senegalense shared 4056, 2905, 4258, 3789 and 4159
orthologous genes with C. haifense, C. indologenes, C. formosense
and E. miricola (Table 5). Among the species with standing in
nomenclature, AGIOS values ranged from 61.15% between
C. haifense and E. miricola to 74.70% between C. formosense and
C. indologenes. The genomic similarity level between strain
FF12T and closely related Chryseobacterium species was also
estimated using the genome-to-genome distance calculator
(GGDC) (Table 6).
ConclusionOn the basis of phenotypic, phylogenetic and genomic analyses,
we formally propose the creation of C. senegalense sp. nov., whichEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 10, 93–100
nses/by-nc-nd/4.0/)
NMNI Lo et al. Chryseobacterium senegalense sp. nov. 99contains strain FF12T. The strain was isolated from the mouth of a
West African lungﬁsh (Protopterus annectens) in Senegal.
Description of Chryseobacterium senegalense
strain FF12T sp. nov.Chryseobacterium senegalense (se.ne.gal.e0n.sis, L. gen. masc. n.
senegalense, pertaining to Senegal, the country where the type
strain was isolated). Isolated from the mouth of a West African
lungﬁsh (Protopterus annectens), C. senegalense is Gram negative,
aeroanaerobic, non–spore forming, a rod and catalase and
oxidase positive. The strain grows easily on 5% sheep’s
blood–enriched Columbia agar with colonies 1 mm in diameter
and comprise aerobic and nonmotile cells with a mean diameter
of 0.75 μm (range 0.5–1 μm) and a mean length of 2.25 μm
(range 1.5–3 μm). Positive reactions were observed for alkaline
phosphatase, phosphatase acid, esterase, lipase, leucine aryla-
midase, α-glucosidase, β-glucosidase, naphthol-AS-BI-
phosphohydrolase, α-fucosidase, β-galactosidase, α-galactosi-
dase, D-glucose, D-maltose and starch. Chryseobacterium sene-
galense strain FF12T is susceptible to amoxicillin, amoxicillin/
clavulanic acid, ceftriaxone, trimethoprim/sulfamethoxazole,
erythromycin, ciproﬂoxacin, nitrofurantoin, doxycycline,
rifampicin and imipenem but resistant to gentamicin and
metronidazole.
The G+C content of the genome is 35.1%. The 16S rRNA
and genome sequences of C. senegalense strain FF12T
(CSUR = P1490, DSM 100279) are deposited in GenBank under
accession numbers LN810503 and CYUH01000001–
CYUH01000015 respectively.AcknowledgementsThe authors thank the Xegen Company (http://www.xegen.fr/)
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